The 2014 Garrod Lecture: EUCAST - are we heading towards international agreement?

Journal of Antimicrobial Chemotherapy

Volumn 70, Issue 9, 2015, Pages 2427-2439

  Kahlmeter, Gunnar ^a  

^a CENTRAL HOSPITAL   (Sweden)

Author keywords

Breakpoints; CLSI; European committee on antimicrobial susceptibility testing

Indexed keywords

ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; DISK DIFFUSION; DRUG INDUSTRY; FINANCIAL MANAGEMENT; FRANCE; GERMANY; HUMAN; INTERNATIONAL COOPERATION; MINIMUM INHIBITORY CONCENTRATION; NETHERLANDS; NONHUMAN; NORWAY; STANDARD; SWEDEN; TARGET ORGANISM; UNITED KINGDOM; BACTERIUM; DRUG EFFECTS; FUNGUS; HEALTH; MICROBIAL SENSITIVITY TEST; PROCEDURES; STANDARDS;

ANTI-INFECTIVE AGENTS; BACTERIA; FUNGI; GLOBAL HEALTH; HUMANS; INTERNATIONALITY; MICROBIAL SENSITIVITY TESTS;

EID: 84953418008     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkv145     Document Type: Article

References (35)

1. Ericsson HM, Sherris JC. Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathol Microbiol Scand B Microbiol Immunol 1971; 217 Suppl: 3-90.
2. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966; 45: 493-6.
3. Kahlmeter G, Brown DF, Goldstein FW et al. European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria. J Antimicrob Chemother 2003; 52: 145-8.
4. The EUCAST General Committee. http://www.eucast.org/organization/general_committee/.
5. EUCAST National AST Committees. http://www.eucast.org/organization/nac/.
6. Translation of EUCAST Documents. http://www.eucast.org/translations/.
7. The EUCAST Antifungal Subcommittee. http://www.eucast.org/ast_of_fungi/.
8. EUCAST Subcommittees. http://www.eucast.org/organization/subcommittees/.
9. Leclercq R, Cantón R, Brown DF et al. EUCASTexpert rules in antimicrobial susceptibility testing. Clin Microbiol Infect 2013; 19: 141-60.
10. Kahlmeter G. Breakpoints for intravenously used cephalosporins in Enterobacteriaceae-EUCAST and CLSI breakpoints. Clin Microbiol Infect 2008; 14 Suppl 1: 169-74.
11. Giske C and the EUCAST Subcommittee for Detection of Resistance Mechanisms and Specific Resistances of Clinical and/or Epidemiological Importance. EUCAST Guidelines for Detection of Resistance Mechanisms And Specific Resistances of Clinical and/or Epidemiological Importance, Version 1.0, December 2013. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Resistance:mechanisms/EUCAST_detection_of_resistance:mechanisms_v1.0_20131211.pdf.
12. Information for Industry on the EUCAST Website. http://www.eucast.org/information_for_industry/.
13. EUCAST Rationale Documents for Antibacterial Agents. http://www.eucast.org/documents/rd/.
14. EUCAST Standard Operation Procedures 1-9. http://www.eucast.org/documents/sops/.
15. EUCAST Rationale Documents for Antifungal Agents. http://www.eucast.org/ast_of_fungi/rationale_documents_for_antifungals/.
16. Harmonisation of European Susceptibility Testing Breakpoints Determined by EMA/CHMP and EUCAST 2005 (Revised 2007 and Reviewed Without Changes 2009). http://www.ema.europa.eu/docs/en_GB/document_library/Standard_Operating_Procedure_-_SOP/2009/09/WC500002942.pdf.
17. Mouton JW, Brown DF, Apfalter P et al. The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach. Clin Microbiol Infect 2012; 18: E37-45.
18. EUCAST Database: Escherichia coli vs. Cefotaxime MICs (Accepted Distributions on 10 April 2015). Updates at: http://mic.eucast.org/Eucast2/regShow.jsp?Id=3217.
19. Turnidge J, Kahlmeter G, Kronvall G. Statistical characterization of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values. Clin Microbiol Infect 2006; 12: 418-25.
20. Kronvall G. Normalized resistance interpretation as a tool for establishing epidemiological MIC susceptibility breakpoints. J Clin Microbiol 2010; 48: 4445-52.
21. Kronvall G, Kahlmeter G, Myhre E et al. A new method for normalized interpretation of antimicrobial resistance from disk test results for comparative purposes. Clin Microbiol Infect 2003; 9: 120-32.
22. Zankari E, Hasman H, Kaas RS et al. Genotyping using wholegenome sequencing is a realistic alternative to surveillance based on phenotypic antimicrobial susceptibility testing. J Antimicrob Chemother 2013; 68: 771-7.
23. Arendrup MC, Kahlmeter G, Rodriguez-Tudela JL et al. Breakpoints for susceptibility testing should not divide wild-type distributions of important target species. Antimicrob Agents Chemother 2009; 53: 1628-9.
24. Juréen P, Angeby K, Sturegård E et al. Wild-type MIC distributions for aminoglycoside and cyclic polypeptide antibiotics used for treatment of Mycobacterium tuberculosis infections. J Clin Microbiol 2010; 48: 1853-8.
25. Sjölund M, Bengtsson S, Bonnedahl J et al. Antimicrobial susceptibility in Escherichia coli of human and avian origin-a comparison of wild-type distributions. Clin Microbiol Infect 2009; 15: 461-5.
26. International Organization for Standardization (ISO). Clinical Laboratory Testing and in Vitro Diagnostic Test Systems. Susceptibility Testing of Infectious Agents and Evaluation of Performance of Antimicrobial Susceptibility Test Devices. Part 1: Reference Method for Testing The in Vitro Activity of Antimicrobial Agents Against Rapidly Growing Aerobic Bacteria Involved In Infectious Diseases. International Standard 20776-1. Geneva, Switzerland: ISO; 2006.
27. Compliance of Manufacturers With EUCAST Recommendations and Terminology. http://www.eucast.org/ast_of_bacteria/compliance:of_manufacturers/.
28. The EUCAST Disk Diffusion Test Method. http://www.eucast.org/ast_of_bacteria/.
29. Matuschek E, Brown DFJ, Kahlmeter G. Development of the EUCASTdisk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories. Clin Microbiol Infect 2014; 20: O255-66.
30. Bengtsson S, Bjelkenbrant C, Kahlmeter G. Validation of EUCAST zone diameter breakpoints against reference broth microdilution. Clin Microbiol Infect 2014; 20: O353-60.
31. Correlations Between MIC and Inhibition Zone Diameters. http://www.eucast.org/ast_of_bacteria/calibration_and_validation/.
32. EUCAST Recommended Quality Control Ranges and Targets and QC Strains. http://www.eucast.org/ast_of_bacteria/qc_tables/.
33. Brown DFJ, Canton R, Dubreuil L et al. Widespread implementation of EUCAST breakpoints for antibacterial susceptibility testing in Europe. Euro Surveill 2015; 20: pii=21008.
34. BSAC. Message to Users of BSAC Disc Diffusion Method-BSAC to Actively Support the EUCAST Disc Diffusion Method for Antimicrobial Susceptibility Testing in Preference to The Current BSAC Disc Diffusion Method From January 2016. http://bsac.org.uk/susceptibility/.
35. International Organization for Standardization (ISO). Clinical Laboratory Testing and In Vitro Diagnostic Test Systems. Susceptibility Testing of Infectious Agents and Evaluation of Performance of Antimicrobial Susceptibility Test Devices. Part 2: Evaluation of Performance of Antimicrobial Susceptibility Test Devices. International Standard 20776-2. Geneva, Switzerland: ISO; 2007.